| Ytd | -9.90% | |
| 1y | -9.90% |
| Open | 16.72 | Prev Close | 16.70 | Low | 16.25 | High | 16.88 | Mkt Cap | 4.69B |
| Vol | 6.42K | Avg Vol | 958.14K | EPS | -0.78 | P/E | -21.55 | Forward P/E | 22.46 |
| Beta | N/A | Short Ratio | 4.96 | Inst. Own | 12.04% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-17 | 50-d Avg | 13.82 | 200-d Avg | 14.19 | 1yr Est | 20.60 |
NORTHRIDGE, Calif., July 20, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabete
Dow falls 296 points. Navitas Semi rises on partnership with Nvidia. Other gainers: ABVX, MMED, KELY
US stock futures rise, Vicor Corp shares dip 2.2% in pre-market trading after beating earnings and s
Goldman Sachs calls Minimed Group a compelling play on the diabetes market and a potentially profit
MiniMed shows improved pipeline and valuation upside as insulin pump adoption grows despite rising c
Wall Street analysts changed outlook on top stocks. See ratings changes for MTRN, AQN, SXT, MMED, an